The Role of Biotechnology in Europe's Responsible Innovation - Speakers
|Latest News||Programme||SME Award||Location|
Dr Andrea Rappagliosi,
Chairman of EuropaBio, Vice President European Government Affairs & Head of Brussels Office GlaxoSmithKline.
Dr Rappagliosi was appointed Chairman of EuropaBio in June 2009.
In April 2009, Andrea joined GlaxoSmithKline as Vice President European Government Affairs & Head of Brussels Office. His work at GSK was preceded by a decade of experience at Merck Serono International where he was Vice President of Health Policy and Market Access in Europe. From 1995 to 1999, he was Public Affairs Director at Baxter Healthcare, part of the European Public Affairs team.
From 2005 to 2008, Dr Rappagliosi was a member of the European Commission High Level Pharmaceutical Forum representing EuropaBio, the European Association for Bioindustry. He sits on the Board of the Foundation of the European Platform for Patients Organizations, Science & Industry (EPPOSI) and is member of HTAi (the International Society of Health Technology Assessment) and founding member of its Policy Forum. In addition, he has been Industry representative at the EMEA/COMP (European Medicines Evaluation Agency/ Committee for Orphan Medicinal Products) Working Group with Interested Parties in the first two terms 2000 to 2005. Dr Rappagliosi is a member of the British Institute of International and Comparative Law and is a member of the Editorial Board of the Journal of Commercial Biotechnology.
Commissioner for Health and Consumer Policy.
In February 2010 John Dalli was appointed as European Commissioner responsible for Health and Consumer Policy.
John Dalli served as a Cabinet Minister in the Maltese Government since 1987 having been first elected to the House of Representatives of Malta on behalf of the Nationalist Party in 1987. He has served as Parliamentary Secretary for Industry (1987-1990), Minister of Economic Affairs (1990-92), Minister of Finance (1992-1996, 1998-2003) Minister of Finance and Economic Affairs and Minister of Foreign Affairs and Investment Promotion (2004). Between March 2008 and February 2010, John Dalli served as Minister for Social Policy which includes the Health, housing, employment and industrial relations portfolio.
As a qualified accountant, Dalli has also worked in the private sector in Malta and abroad, both in industry and as an independent consultant.
Sandra E. Peterson
Chief Executive Officer, Bayer CropScience AG
Sandra E. Peterson joined the Bayer CropScience Board of Management on July 1, 2010. As of October 1, 2010 she has succeeded Prof. Friedrich Berschauer as the new Chief Executive Officer. Ms Peterson has been a member of the Executive Committee of Bayer HealthCare since May 2005, heading up the Medical Care Division since January 2009. Prior to that she was in charge of the Diabetes Care Division, now one of the businesses of Medical Care.
In 1999 Peterson became Senior Vice President of Merck-Medco's Health Businesses, where she launched several new business lines. Her areas of responsibility at Medco included business development, strategy, cooperation management, product development, branding and marketing. As an Executive Management team member, she played a role in the strategic spin-off of Medco Health from Merck & Co., Inc., latterly serving as Group President of Medco Health. Between 1993 and 1996 she held various global executive positions with home appliances manufacturer Whirlpool Corporation, subsequently being appointed Executive Vice President at foods company Nabisco. From 1987-1993, Peterson was a management consultant at McKinsey & Company, working on brand marketing strategies, innovative product development and new business.
Ms Peterson holds a B.A. in Government from Cornell University, Ithaca, N.Y., and a Master of Public Administration in Applied Economics from the University of Princeton, New Jersey. She received a fellowship from the Robert Bosch Foundation in Stuttgart, Germany, and spent a year in 1984-85 serving with the German Federal Ministry of Finance and the Federation of German Industries.
Maria Gabriela Cruz
In a country prone to soil loss, Maria Gabriela Cruz employs no-till and reduced-till farming methods to cut erosion on her farm by as much as 70 percent and to improve soil fertility. The fourth-generation farmer with a master’s degree in farming management dreams of the potential of biotech crops to further protect her soil. All the hectares on her family’s farm are part of an Environmental Protected Area, under Conservation Agriculture: No-Till and Zone-Till for the last 12 years. “We need a biotech crop that is resistant to herbicides,” she says. Cruz believes biotech crops will enable Portugal’s farmers to use conservation agriculture practices that leave crop residue on the surface to fight water and wind erosion and allow a significant increase in carbon sink in the soil. “Biotech crops are the way to keep farmers on the land,” she says. “If we don’t have biotech crops, we will become less competitive and have to import more food.”
Member of the Executive Board and General Partner of Merck KGaA
In 2006, Elmar Schnee was appointed Member of the Executive Board of Merck KGaA and General Partner of Merck KgaA, having previously been appointed Deputy Member of the Executive Board and Head of the Pharmaceuticals business sector in 2005. In May 2003, Mr Schnee took a directorship position at the Merck subsidiary Merck Santé S.A.S. in Lyon, France. In addition to his duties at the French subsidiary, he assumed responsibility for the global operations of the Ethicals division in January 2004 and was named Head of the Ethicals division in 2005.
In 1999, he joined UCB Pharma in Brussels, initially as Group Director Global Marketing, Licensing and Strategy and later as Managing Director of UCB Farchim S.A., a global pharmaceutical firm headquartered in Switzerland. . In 1988, he joined the Swiss subsidiary of UK-based Fisons Pharmaceutical as Marketing and Sales Director. He transferred to the company’s UK headquarters in 1992 and was appointed Head of CNS and CV Marketing worldwide. Schnee took a position as Vice President Consulting at U.S.-based Migliara/Kaplan Associates in 1996 before moving to Paris as the Director of the Business Unit Thrombosis for Sanofi-Synthélabo in 1997.
Mr Schnee started his career at a Swiss advertising agency and then pursued a series of management positions in marketing and sales in the consumer goods industry. He received a degree in Marketing Management at the Zurich-based Schweizerisches Institut für Betriebsökonomie (Swiss Institute for Business Administration).
Robert Johnstone is a trustee & IAPO representative from National Voices in the UK (a coalition representing more than 200 health & social care organizations). Having had chronic rheumatoid arthritis for more than 50 years, he has not had a conventional career but has served on many charities representing disabled people & those with health challenges. For many years he has been very active in a network called People with Arthritis & Rheumatism in Europe where he was involved in lobbying the European Parliament & senior policy makers to raise the profile of musculoskeletal conditions. At a global level he served as President of Arthritis & Rheumatism International (ARi) and worked in the Bone & Joint Decades as a patient advocate.
President - DuPont Europe, Middle East & Africa and President - Du Pont de Nemours International SA Geneva
Ian Hudson is president - DuPont Europe, Middle East & Africa, and president - Du Pont de Nemours International SA Geneva. A former European business director of ICI's Polyester Films business, he joined DuPont in 1998, when the company acquired that business, and became regional director Europe for DuPont Polyester Films. After spending 5 years in Wilmington, Del., as global business director - Sorona®/Bio-PDO™ in the DuPont Bio-Based Materials business, he relocated to Geneva, Switzerland, in 2004, when he was named regional director - DuPont Advanced Fiber Systems and DuPont Nonwovens. He was named to his current position in April 2006.
After graduating from Oxford University with an MA degree in French and German, Mr. Hudson's career with ICI spanned 18 years, during which time he held a number of commercial and business management roles, including assignments in France and in the United States, as well as extensive travel in Asia.
Mr. Hudson is a member of the Executive Committee and Board of CEFIC (European Chemical Industry Association), chairman of the Industrial Biotech Council and member of the Board of EuropaBio (European Association of bio industries), member of the Board of the Swiss-American Chamber of Commerce, and member of the Foundation Board of the International Institute for Management Development (IMD).
ETP for future of textiles and clothing, Euratex
Lutz Walter is Head of the R&D, Innovation and Projects Department of Euratex, the European Apparel and Textile Confederation based in Brussels. He is also Secretary of the Governing Council of the European Technology Platform for the Future of Textiles and Clothing since its establishment in 2004. Since 1999 he has followed EU research policies and programmes and developed strategies and position papers on the future of textile and clothing research and innovation in Europe.
"Research priorities of the European Technology Platform for the Future of Textiles and Clothing and the cross-platform initiative ManuTex "
Advanced fibre- and textile-based materials are increasingly discovered as a material of choice for a broad range of high added value applications addressing many key societal challenges. These high-tech materials and products are manufactured using high-speed, flexible and increasingly digital production technologies in complex value chains and production networks. Research priorities for this industry consequently cover a wide range of subjects including nanotechnology, material science, production technologies.
Thomas Reese Saylor
Chief Executive Officer, Arecor Ltd. representing BIA
Chair of the SME Platform
In 2009 EuropaBio launched its SME platform, appointing Tom Saylor as its chair. The SME Platform brings together various stakeholders, including CEOs of SMEs, National Biotech Associations, venture capitalists and private banks, European financial institutions, and representatives from the EU, and aims highlight the challenges and financial constraints that biotech SMEs face as well as develop policy recommendations to optimise EU and member state funding instruments for biotech SMEs.
Tom has a background in management, strategy development, deal negotiation and fundraising for entrepreneurial biopharmaceutical companies. He currently works as the CEO of Arecor Ltd, a pharmaceutical company which Arecor Ltd. develops stabilization technology solutions for pharmaceutical and biotech companies developing recombinant proteins and vaccines for application in drugs, medical devices, or diagnostics.
He has previously held key board positions for Sirus Pharmaceuticals Limited, Lotus Healthcare Corporation and Cell Systems Limited. Tom was also a principal trade negotiator for the United States during the Tokyo Round.
Tom holds an MBA from Harvard University, doctoral studies in molecular biology at the Max Planck Institute for Psychiatry in Munich and a degree in molecular biology from the Georgia Institute of Technology.
Professor of Business Economics and Game Theory, KULeuven (BE)
Prof Dr. Reinhilde Veugelers is a full-time professor at KULeuven (BE) at the Faculty of Economics and Business, where she teaches international business economics and game theory. From 2004-2008, she was on academic leave, as advisor at the European Commission (BEPA Bureau of European Policy Analysis). She is currently a Senior Fellow at Bruegel, a CEPR Research Fellow. She is also co-promoting ECOOM, the Flemish Center for R&D Monitoring. She was a visiting scholar at Northwestern University’s Kellogg Graduate School of Management, Sloan School of Management, MIT, Stern Business School, NYU (US), UCL (BE), ECARES/ ULBrussels, (BE) Paris I (FR) UPF & UAB-Barcelona (ES), UMaastricht (NL) and is currently visiting faculty at the MSI program of the Barcelona UPF-UAB Graduate School.
With her research concentrated in the fields of industrial organisation, international economics and strategy, innovation and science, she has authored numerous publications in leading international journals. Her research combines analytical frameworks, using micro-economics, game theory and economics of information models, with empirical, mostly econometric testing on large datasets. Specific recent topics include incentives for innovation activities, international technology transfers through MNEs, impact on local R&D of multinational competition, internal and external technology sourcing, alliances and their stability, inter-company technology transfers through cooperation, young innovative companies, industry science links and their impact on firm’s innovative productivity, performance of technology transfer offices at universities, designing university spin-off contracts, explaining scientific productivity: persistency and skewness, researchers’ international mobility. Recent policy topics include: university governance and higher education reforms, financing innovation for young radical innovators, innovation policy indicators, innovation strategies for catching-up countries, and innovation for climate change.
José Manuel Barroso
President European Commission
José Manuel Barrosowas born in Lisbon on 23 March 1956. After graduating in law from the University of Lisbon, he moved to Geneva where he completed a Diploma in European Studies at the European University Institute, University of Geneva, and a Master's degree in Political Science from the Department of Political Science, Faculty of Economics and Social Sciences, University of Geneva, earning an honours in both.
He embarked on an academic career, working successively as a teaching assistant at the Law Faculty of the University of Lisbon, int the Department of Political Science, University of Geneva, and as a visiting professor at the Department of Government and School of Foreign Service, Georgetown University (Washington, D.C.). In 1995, he became Head of the International Relations Department of Lusíada University, Lisbon. In 1979, he founded the University Association for European Studies.
His political career began in 1980 when he joined the Social Democratic Party (PSD). He was named President of the party in 1999 and re-elected three times. During the same period, he served as Vice President of the European People's Party. In April 2002, he was elected Prime Minister of Portugal. He remained in office until July 2004 when he became President of the European Commission. He was re-elected for another five year term by the European Parliament in September 2009.
José Manuel Barroso was awarded honorary degrees by Roger Williams University, Rhode Island (2005), Georgetown University, Washington, D.C. (2006), University of Genoa, Italy (2006), University of Kobe (2006) and Sapienza University of Rome (2007). He was also declared "European of the year 2006" by the magazine European Voice. He is the author of numerous publications on political science, international relations and the European Union, including "Le système politique portugais face à l'intégration européenne", Lisbon and Lausanne, 1983; "Uma Certa Ideia de Europa", 1999; "Mudar de Modelo", 2002 and "Reformar: Dois Anos de Governo", 2004.
Paola Testori Coggi
DG Health and Consumers Policy, European Commission
Paola Testori Coggi is Director General in the Directorate- General for Health and Consumers of the European Commission since April 2010. In July 2007 she became Deputy Director General for Health and Consumers with specific responsibility for food safety and animal health, inspections and scientific matters. Since 2000, as Director for the Safety of the food chain, she has been responsible for the White Paper on food safety and the legislative action programme as well as the management of emergencies. She was previously Advisor for consumer health in the Cabinet of Commissioner Emma Bonino and she worked on the definition of the new EU policy on consumer health after the food safety crisis. Paola Testori Coggi joined the European Commission in 1983 in the Directorate-General for Environment where she worked until 1989 in the field of the control of dangerous chemicals and industrial risks. Afterwards, she served as Member responsible for the research programmes on life sciences, environment and energy in the Cabinet of the Vice-President of the European Commission, Filippo Maria Pandolfi. She also worked in the EU Joint Research Centre where she was responsible for administrative coordination. Paola Testori Coggi is a biologist from the University of Milan, Italy, with a Master degree in Ecotoxicology. In 2008 she received a Doctor Honoris Causa in Veterinary Medicine at the University of Cluj, Romania.
Secretary General, EuropaBio
In April 2010, Nathalie was appointed Secretary General of EuropaBio, bringing with her a wealth of experience in the biotech industry and European public policy.
In addition to her academic background in biochemistry and biotechnology, Nathalie has worked at national and EU level on biotechnology related legislation and acceptance and has since spent more than a decade representing the European Biotechnology Industry through EuropaBio in the posts of External Relations Manager, Director for Strategic Policy, Director of the Healthcare Biotech sector, Director of the Agricultural Biotech sector and most recently as Secretary General.
In the course of her career, Nathalie has focused on improving awareness of the importance and benefits of biotechnology for Europeans and has worked, together with the industry, regulators and stakeholders, towards developing a more supportive legislative framework for the industry and related sectors.